Corneal microcysts

British Journal of Ophthalmology

Volumn 98, Issue 1, 2014, Pages

  Dhillon, Virinder K ^a   Faraj, Lana A ^a   Elalfy, Mohamed S ^a,b   Bhatt, Uday ^a   Said, Dalia G ^a,b   Dua, Harminder S ^a  

^a NOTTINGHAM UNIVERSITY HOSPITALS NHS TRUST   (United Kingdom)

^b RESEARCH INSTITUTE OF OPHTHALMOLOGY   (Egypt)

Author keywords

[No Author keywords available]

Indexed keywords

CYTARABINE; DEXAMETHASONE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ARTICLE; BLURRED VISION; CANCER CHEMOTHERAPY; CASE REPORT; CHILD; CORNEA DISEASE; CORNEAL MICROCYST; DRUG MEGADOSE; ERYTHEMA; EYE DISCOMFORT; EYE EXAMINATION; HUMAN; IMAGE ANALYSIS; MALE; PRIORITY JOURNAL; SCHOOL CHILD; SLIT LAMP; TREATMENT RESPONSE; VISUAL ACUITY; VISUAL ACUITY CHART;

CORNEA; DRUGS; OCULAR SURFACE; PHARMACOLOGY; TREATMENT MEDICAL;

ANTIMETABOLITES, ANTINEOPLASTIC; CHILD; CORNEAL OPACITY; CYSTS; CYTARABINE; DIAGNOSIS, DIFFERENTIAL; HUMANS; MALE;

EID: 84890555915     PISSN: 00071161     EISSN: 14682079     Source Type: Journal    
DOI: 10.1136/bjophthalmol-2013-303705     Document Type: Article

References (10)

1. Stentoft J. The toxicity of cytarabine. Drug saf 1990;5:7-27.
2. Guthoff T, Tietze B, Meinhardt B, et al. Cytosine-arabinoside-induced keratopathy: a model of corneal proliferation kinetics. Ophthalmologica. Ophthalmologica 2010;224:308-11.
3. Hopen G, Mondino BJ, Johnson BL, et al. Corneal toxicity with systemic cytarabine. Am J Ophthalmol 1981;91:500-4.
4. Ehlers N, Hjortdal J, et al. Phenotypic variability in Meesmann's dystrophy: clinical review of the literature and presentation of a family genetically identical to the original family. Acta Ophthalmol 2008;86:40 -4.
5. Butros S, Lang GK, et al. The different opacity patterns of Lisch corneal dystrophy. Klin Monbl Augenheilkd 2006;223:837-40.
6. Herzig RH, Wolff SN, Lazarus HM, et al. High-dose cytosine arabinoside therapy for refractory leukemia. Blood 1983;62:361-9.
7. Itoh M, Aoyama T, Yamamura Y, et al. Effects of the rational use of corticosteroids eye drops for the prevention of ocular toxicity in high-dose cytosine arabinoside therapy. Yakugaku Zasshi 1999;119:229-35.
8. Kaufman HE, Capella JA, Maloney ED, et al. Corneal Toxicity of Cytosine Arabinoside. Arch Ophthalmol 1964;72:535-40.
9. Lochhead J, Salmon JF, Bron AJ. Cytarabine-induced corneal toxicity. Eye (Lond) 2003;17:677-8.
10. Gressel MG, Tomsak RL. Keratitis from high doses intravenous cytarabine. Lancet 1982;2:273.